'Price would have to fall five-fold' for HSE to afford Cystic Fibrosis drug Orkambi

There are calls for the company behind a Cystic Fibrosis drug to put their patients before profits.

It emerged at the weekend that the HSE views the drug Orkambi, which is manufactured by Vertex, as "unjustifiably expensive".